Ocugen Inc. stock falls Wednesday, underperforms market
Shares of Ocugen Inc. OCGN shed 5.16% to $0.83 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 5,918.25 and the Dow Jones Industrial Average DJIA rising 0.
Maxim Group has recently initiated Ocugen Inc (OCGN) stock to Buy rating, as announced on October 15, 2024, according to Finviz. Earlier, on March 1, 2023, Chardan Capital Markets had raised the stock ...
Geode Capital Management LLC grew its stake in shares of Ocugen, Inc. (NASDAQ:OCGN – Free Report) by 6.3% in the third quarter, according to its most recent disclosure with the SEC. The fund owned ...
OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced the pricing of its underwritten public offering of ...
Ocugen Inc (OCGN) stock saw a modest uptick, ending the day at $0.9 which represents a slight increase of $0.09 or 11.11% from the prior close of $0.81. The stock opened at $0.87 and touched a low of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback